← AXE

AXEARCHER MATERIALS LIMITED

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
19 Aug 2026, 00:12Results of General MeetingMeetings & Governance—08003
13 Aug 2026, 19:27Early Pre-Pilot Study Advances Potassium BiosensorCompany UpdateMS11001
10 Aug 2026, 19:53Application for quotation of securities - AXEOther—06020
10 Aug 2026, 19:50Results of Share Purchase PlanCapital Raising—06017
29 July 2026, 19:32Biochip Advances Towards Clinical-Ready Device DevelopmentCompany UpdateMS11001
17 July 2026, 19:17Notice of General Meeting/Proxy FormMeetings & Governance—08004, 08007
10 July 2026, 19:07Dispatch of Share Purchase Plan Offer BookletCapital Raising—06010, 06017
9 July 2026, 19:46Completion of A$6.86m Tranche 1 Placement, s708A NoticeSecurities Administration—06018
9 July 2026, 19:38Application for quotation of securities - AXEOther—06020
9 July 2026, 19:23Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19004, 19009
4 July 2026, 02:05AXE to host webinar - IonQ Strategic Partnership and SPPCapital Raising—06017, 14014
3 July 2026, 20:02Proposed issue of securities - AXESecurities Administration—06013
3 July 2026, 20:02Presentation - Bringing Quantum Computing to AustraliaPresentationsMS03026
3 July 2026, 20:02Archer Completes $7m Placement and Launches SPP OfferCapital RaisingMS06003, 06017, 09014
1 July 2026, 19:27Archer enters strategic agreement with quantum leader, IonQCompany UpdateMS11001
1 July 2026, 19:03Trading HaltTrading Halt / SuspensionMS09007
27 June 2026, 03:04Notification of cessation of securities - AXEOther—06027
15 June 2026, 19:38AXE advances quantum strategy amid growing global momentumCompany Update—11001
4 June 2026, 23:56Archer QML Project achieves key milestonesCompany UpdateMS11001
22 May 2026, 02:41Notification of cessation of securities - AXEOther—06027
15 May 2026, 19:20Biosensor beta prototype and manufacturing pathway advancedCompany UpdateMS11001
12 May 2026, 19:17Archer strengthens pathway to quantum device manufacturingCompany UpdateMS11001
4 May 2026, 19:24Archer to host quarterly update investor webinarPresentations—14014
29 Apr 2026, 19:31Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19003, 19008
23 Apr 2026, 03:37Notification of cessation of securities - AXEOther—06027
7 Apr 2026, 20:30Biochip advances toward beta prototype & clinical validationCompany UpdateMS11001
18 Mar 2026, 20:19Archer to commence QML simulations and benchmarkingCompany Update—11001
4 Mar 2026, 20:141H FY26 Update - PresentationFinancial Results—03004, 03026, 14014
25 Feb 2026, 20:45Appendix 4D and Half Year Financial ReportFinancial ResultsMS03004, 03009, 03010, 03015, 03019, 14014
12 Feb 2026, 20:30Quantum program advances with ecosystem-led executionCompany Update—11001
30 Jan 2026, 20:21Archer develops early Biochip prototypeCompany UpdateMS11001
29 Jan 2026, 21:39Investor Webinar - PresentationPresentations—03026, 14014, 19007
29 Jan 2026, 20:22Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS14014, 19002, 19007
22 Jan 2026, 19:25Archer to host quarterly update investor webinarCompany Administration—12008
9 Jan 2026, 20:26Letter to ShareholdersLetters & Addresses—16002
2 Dec 2025, 01:32Final Director's Interest Notice - KWDirector Interests—02010
2 Dec 2025, 01:32Initial Director's Interest Notice - AJDirector Interests—02008
2 Dec 2025, 01:31Archer Board ChangesCompany Administration—12001
21 Nov 2025, 05:28Change of Director's Interest Notice - GEDirector Interests—02009
21 Nov 2025, 05:26Notification regarding unquoted securities - AXEOther—06021
20 Nov 2025, 23:13Results of 2025 Annual General MeetingMeetings & Governance—08003
20 Nov 2025, 21:14AGM PresentationPresentations—03026, 15002
20 Nov 2025, 21:12Chair's 2025 AGM addressLetters & Addresses—15002
20 Nov 2025, 19:30AXE achieves readout milestone towards qubit demonstrationCompany UpdateMS11001
10 Nov 2025, 20:11AXE & CSIRO - Quantum Machine Learning for fraud detectionCompany UpdateMS11001
3 Nov 2025, 20:48Notification of cessation of securities - AXEOther—06027
29 Oct 2025, 20:17Silicon Biochip meets performance and clinical requirementsCompany UpdateMS11001
27 Oct 2025, 19:23Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19001, 19006
22 Oct 2025, 19:27Presentation - Semiconductor Australia 2025Presentations—03026
22 Oct 2025, 03:19Notice of Annual General Meeting/Proxy FormMeetings & Governance—08001, 08004
1–50 of 60
1 / 2